D. Li et al.
Bioorganic Chemistry 108 (2021) 104642
synthesized dehydrobrachylaenolide (3) from tuberiferin (1). Enolsily-
lation of 1 with TMSOTf and Et3N in CH2Cl2 and successive treatment of
the resulting silyl enol ether with PTAB gave bromide 29 in 79% yield.
Dehydrobromination of 29 with Li2CO3 and LiBr in DMF afforded 3 in
82% yield. On the contrary, treatment of the silyl enol ether with Pd
(OAc)2 gave 3 and 30 in 9% and 56% yields, respectively. The physical
constants and spectral data of 3 were in good agreement with those of
natural dehydrobrachylaenolide (3) in the literature [12] (Scheme 1).
most active compound was trans-
α
-methylene γ-lactone with exo-end
cross conjugated carbonyl moiety (3, IC50 3.0 μM) followed by trans-
α
-methylene γ-lactone with
and it’s cis- counterpart (19, IC50 6.1
with ,β-unsatrated carbonyl moiety (1, IC50 7.1
counterpart (2, IC50 7.3 M). In -methylene γ-lactones, change of
,β-unsaturated carbonyl moiety of 1 to exo-end cross conjugated
carbonyl moiety of 3, and change of 3-carbonyl moiety of 24 to 2
bromo-3-carbonyl moiety of 25 showed 2.5 and 3.3 folds stronger ac-
tivity, respectively. In cis- -methylene γ-lactones, change of 3-carbonyl
moiety of 18 to -bromo-3-carbonyl moiety of 19, and change of
,β-unsatrated 3-carbonyl moiety of 2 to -bromo-3-carbonyl moiety of
19 showed 3 and 1.2 fold stronger activity, respectively. Change of
-methyl γ-lactone moiety of 20 to -methylene γ-lactone moiety of 19,
and Change of -methyl γ-lactone moiety of 27 to -methylene γ-lactone
moiety of 1 showed 3.6 and 7.6 fold stronger activity, respectively.
Therefore, a conclusion could be reached that an -methylene
γ-lactone moiety in the molecule is essential for the activity, moreover,
-bromo-3-carbonyl moiety, exo-end cross conjugated carbonyl moiety,
and ,β-unsturated carbonyl moiety are responsible for the increment of
the activity of corresponding -methylene γ-lactones (see Table 1). In
α
-bromoketone moiety (25, IC50 5.2
M), trans- -methylene γ-lactone
M) and it’s cis-
μM)
μ
α
α
μ
μ
α
α
α
-
α
2.2. Immuno-modulating and Anti-inflammatory activities of compounds
α
α
α
2.2.1. Anti-inflammatory Activities of Compounds Based on Inhibitory
Activity on Expression of Intercellular Adhesion Molecule (ICAM-1) Induced
by Interleukin-1 (IL-1)
α
α
α
α
Expression of intercellular adhesion molecule-1 (ICAM-1) is induced
by interleukin-1 (IL-1) on the surface of endothelial cells of blood ves-
sels. ICAM-1 on the activated endothelial cells interacts with lympho-
cyte function-associated antigen-1 (LFA-1) on leucocytes in the blood
stream, and the leucocytes begin rolling, adhere to the surface of
endothelium, and finally migrate from the inside of the blood vessel to
the inflammatory portion by chemotaxis. The attack of leucocyte causes
serious damage to the inflammatory tissue. Expression of excess amount
of ICAM-1 on the surface of endothelial cells of blood vessel plays an
important role in the progress on inflammatory reaction [13]. These
facts suggest that the inhibitors of induction of ICAM-1 may turn out to
yield a new type of anti-inflammatory agent.
α
α
α
α
addition, the activities of eudesmane-12,6α-lactones (trans-lactones) are
higher than those of the corresponding eudesmane-12,6β-lactones (cis-
lactones).
The transcription of the ICAM-1 gene induced by IL-1 is largely
depended on the transcription factor NF-κB. Upon IL-1 stimulation, NF-
κB translocates from the cytoplasm into the nucleus and activates variety
In the present study, two series of eudesmanolides, eudesmane-
of target genes. As reported previously [12,14], trans-α-methyl γ-lactone
12,6α-lactones (trans-lactones, 1, 3, 10, 11, 22–27) and eudesmane-
with
α-bromoketone moiety (26) and the compounds possessing an
12,6β-lactones (cis-lactones, 2, 7, 8, 16–21), were tested for the inhib-
α
-methylene γ-lactone moiety control the signaling pathway upstream of
itory activity of induction of ICAM-1.
the nuclear transcription of NF-κB, which gives a hint of the potential
mechanism of the above tested active compounds, and further research
is under consideration.
As shown in Table 1, all compounds possessing
α-methylene
γ-lactone moiety (1, 3, and 23–25 in trans-lactones and 2, and 17–18 in
cis-lactones) showed significant inhibitory activity on the induction of
ICAM-1. In α-methyl γ-lactones, α-bromoketons 26 with trans-lactone
2.2.2. Inhibitory activity of the test samples against the permeation of
leucocyte into inflammatory air pouch of murine in vivo
structure and 20 with cis-lactone structure showed significant activity.
,β-Unsaturated ketones 27 and 21 with trans- and cis- -methyl
γ-lactone ring showed moderate and weak activity, respectively. Other
trans- -methyl γ-lactones, 10, 11, and 22 and cis- -methyl γ-lactones, 7,
8, and 16 showed no activity. The order of the inhibitory activity of
α
α
The leucocytes migrate from the inside of the blood vessel to the
inflammatory portion by chemotaxis in the final stage of inflammatory
reaction. Since the attack of leucocyte causes serious damage to the
inflammatory tissue in this stage, the compounds possessing the inhib-
itory activity of permeation of leucocyte may be anti-inflammatory
agents [15]. Thus, we examined the assay of anti-inflammatory activ-
ity of compounds using inflammatory air pouch of murine in vivo. As
α
α
eudesm-12,6α-lactones (trans-lactones) on induction of ICAM-1 was 3 >
25 > 1 > 26 > 23 > 24 > 27≫>≫10, 11, 22, and the order of the
inhibitory activity of 3-oxoeudesm-12,6β-lactones (cis-lactones) on in-
duction of ICAM-1 was 19 > 2 > 18 > 17 > 20 > 21>>>7, 8, 16. The
Table 1
Inhibitory Activity on Induction of ICAM-1 of trans- and cis-lactonesa
Compounds
IC50
(μM)
SDEV (%)
Compounds
IC50
(
μM)
SDEV(%)
trans-α-methyl γ–lactone
cis-α-methyl γ-lactone
10
11
22
26
27
>1000
>316
>1000
11.1
7
>1000
>1000
>1000
22.5
8
16
20
21
1.9
4.8
1.2
2.2
59.0
164.7
trans-
α
-methylene γ-lactone
cis-
α-methylene γ-lactone
23
24
25
3
7.7
4.3
4.1
1.1
4.8
4.2
3.4
2.9
4.6
2.7
17
18
19
2
19.1
18.3
5.4
0.9
8.4
3.0
2.4
7.2
1
a
A549 cells (3 × 104 cells/well) were pretreated with various concentrations of compounds for 1 h and then incubated in the presence of IL-1β for 6 h. Absorbance of
415 nm was assayed after treatment of the cells with primary and secondary antibodies and addition of the enzyme substrate as described in the Materials and Methods
for Bioassays. The experiments were carried out in triplicate cultures. IC50 was caluculated by using the formula in Materials and Method for Bioassay.
4